What to Expect at Maui Derm NP+PA Fall 2026

Maui Derm NP+PA Fall 2026 brings dermatology nurse practitioners and physician assistants to The Greenbrier in White Sulphur Springs, West Virginia, from September 16 to 19 for 4 days of clinical education spanning new therapies, inflammatory skin disease, oncology, pediatric dermatology, acne, psoriasis, rare disease, and more.

The meeting combines traditional clinical updates with interactive case discussions, audience-response sessions, workshops, and diagnostic challenges designed to translate emerging evidence into everyday dermatology practice. Across the program, faculty will address both common conditions encountered routinely in clinic and complex cases that can test clinicians’ diagnostic and therapeutic decision-making.

New Data and Emerging Therapies

The meeting opens with a review of noteworthy dermatology literature published in 2026, followed by a session focused on new products and therapies and how clinicians may incorporate them into practice in 2026 and beyond.

That focus on evolving treatment options continues throughout the meeting. Sessions will examine new data and approaches across atopic dermatitis, psoriasis and psoriatic arthritis, hidradenitis suppurativa (HS), chronic spontaneous urticaria, connective tissue disorders, acne, rosacea, and other disease states.

One session will also explore the emerging role of glucagon-like peptide-1 receptor agonists in psoriasis and the intersection between metabolic disease, inflammation, and dermatologic treatment. An inflammation and immunology workshop will then examine new drugs, data, and treatment approaches in HS, connective tissue disorders, urticaria, and related conditions through challenging clinical scenarios.

Interactive Cases Put Clinical Decision-Making to the Test

Case-based learning is a major component of this year's program. Cutaneous oncology sessions will take attendees through diagnostic and therapeutic dilemmas ranging from actinic keratoses to advanced nonmelanoma skin cancer, with participants weighing in on treatment decisions before faculty discuss their clinical reasoning.

Similar interactive formats will appear throughout the conference, including Grand Rounds in Dermatology, eczematous and contact dermatitis cases, and inflammation and immunology workshops.

The meeting's Skin Lesions Potpourri will add a competitive element, presenting clinical photographs of difficult-to-diagnose lesions and asking attendees to vote on their diagnoses while a real-time leaderboard tracks responses.

Updates Across Atopic Dermatitis, Acne, and Psoriasis

Friday's program will feature several broad clinical updates beginning with pediatric dermatology, followed by an interactive session on atopic dermatitis and itch. Faculty will discuss new drugs, data, and treatment approaches before applying those developments to challenging patient scenarios.

Acne and rosacea will receive a dedicated interactive update led by Hilary Baldwin, MD, and Julie Harper, MD, with faculty reviewing current treatment approaches before turning to case-based therapeutic decision-making.

A 2-hour psoriasis and psoriatic arthritis update will explore developments from the past year as well as complex treatment decisions involving comorbidities and clinical circumstances such as pregnancy, solid tumors, obesity and metabolic syndrome, and tuberculosis.

Rare Diseases, Pigmentation, and Diagnostic Challenges

Saturday's agenda shifts toward several areas in which diagnosis itself can be challenging. A session on blistering diseases will ask attendees to work through both diagnostic and therapeutic choices, followed by “NIRDS,” or Novel Insights for Rare Diseases, which will highlight practical approaches to diagnosing and treating select rare and complex dermatologic conditions.

Pigmentary disorders will also take center stage, with discussion of melasma, vitiligo, differential diagnosis, and evolving management strategies. The subsequent Pigmented Lesion Clinic will bring together experts to work through cases spanning congenital nevi through metastatic melanoma.

The conference concludes with an extended dermoscopy workshop emphasizing interpretation of dermoscopic features, algorithms and pattern analysis for skin cancer detection, and applications of dermoscopy in infections, rashes, and hair loss.

Practical Pearls for the Dermatology Clinic

Beyond updates on drugs and disease states, Maui Derm NP+PA Fall 2026 places an emphasis on skills clinicians can bring directly back to practice. A procedural pearls session will focus on refining dermatologic surgical techniques, improving efficiency, and incorporating technical strategies beyond basic procedural skills.

Other sessions will tackle infectious diseases, nail disorders, uncommon dermatoses, pediatric dermatology, and diagnostic challenges, creating a program that spans both high-frequency concerns and less familiar presentations.

Across 4 days, the meeting's combination of emerging evidence, expert discussion, audience participation, and case-based education will offer NPs and PAs opportunities to sharpen clinical decision-making while staying current with a rapidly changing dermatology treatment landscape.